Related books on 'monoclonal-antibody'
Return to life science book listNumber of products: 25573
Page 2 of 2558
|
by: Pete Gagnon publisher: Validated Biosystems Inc, published: 1996-01-31 ASIN: 0965351599 EAN: 9780965351591 sales rank: 3012865 |
|
|
by: J. Eryl Liddell publisher: Wiley, published: 1991-05-06 ASIN: 0471929050 EAN: 9780471929055 sales rank: 3236443 Includes all of the information required to produce monoclonal antibodies in the laboratory and to prepare them for use in a multitude of given applications. Production procedures are treated in chronological order, beginning with basic tissue culture techniques, immunization strategies and screening test design, followed by production of hybridoma cell lines and basic antibody characterization, purification and labeling. Each chapter contains explanatory text on each step with comparative analysis of methods where appropriate. All necessary experimental protocols are presented in a self-contained format that is easy to follow in the laboratory. Alternative protocols are provided where relevant; for others not included in full, source references are presented. Surveys the current status of human hybridoma production and antibody engineering using molecular biology techniques. |
|
publisher: Academic Press, published: 1986-06-11 ASIN: 0121820211 EAN: 9780121820213 sales rank: 3335806 The critically acclaimed laboratory standard, Methods in Enzymology, is one of the most highly respected publications in the field of biochemistry. Since 1955, each volume has been eagerly awaited, frequently consulted, and praised by researchers and reviewers alike. The series contains much material still relevant today - truly an essential publication for researchers in all fields of life sciences. |
|
by: Kenneth C. McCullough publisher: Cambridge University Press, published: 1990-04-27 ASIN: 0521258901 EAN: 9780521258906 sales rank: 4841199 This volume provides a complete description of the principles, methodologies and applications of monoclonal antibodies, one of the most exciting developments to occur in biotechnology in recent years, and a powerful technology for modern industry and science. The immune system and the role of the antibody are described and full details are given on how the hybridomas are formed, isolated, and maintained in culture such that the required antibody can be produced to a high degree of purity. The authors describe all the methodologies involved, all the reagents and solutions and all the assay conditions required for their production. The material is presented to enable research and development managers to make choices as to which are the most suitable techniques for their requirements. The book is comprehensively referenced, and will be a necessary resource for all those who are involved with this technology. |
|
publisher: Academic Press, published: 1983-04-11 ASIN: 0121819922 EAN: 9780121819927 sales rank: 3893993 FROM THE PREFACE: Several papers in this volume deal with advances in hybridoma technology and complement the chapter by Galfri and Milstein that appeared in Volume 73 of this series. Methods to enhance the efficiency of producing desired fusion products, to simplify the basic procedures involved, and to assess the specificity and other properties of monoclonal antibodies are discussed. Representative examples illustrate how a battery of monoclonal antibodies with different specificities can be used to study various immunochemical and biochemical problems. Other chapters cover additional procedures that can be used to label antigens and antibodies, separate antigen-antibody complexes, and process data. Some papers classified under one heading or contained in another volume of the series include methods that can be applied in other specific areas. For example, cytotoxicity tests described in Volume 93 may be used to screen supernatant fluids in hybridoma experiments if cytotoxic activity is a desirable property of the monoclonal antibody. |
|
publisher: Springer, published: 1988-09-01 ASIN: 0306429829 EAN: 9780306429828 sales rank: 11137400 |
|
by: Icon Group International publisher: ICON Group International, Inc., published: 2009-07-07 ASIN: 0546940765 EAN: 9780546940763 This econometric study covers the world outlook for Monoclonal Antibody (MAb)-based products across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-a-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E. for Monoclonal Antibody (MAb)-based products. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business. |
|
by: Icon Group International publisher: ICON Group International, Inc., published: 2009-07-07 ASIN: 0546941516 EAN: 9780546941517 sales rank: 7936179 This econometric study covers the world outlook for therapeutic Monoclonal Antibody (Mab)-based products across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-a-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E. for therapeutic Monoclonal Antibody (Mab)-based products. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business. |
|
by: Bala Swaminathan publisher: Marcel Dekker Inc, published: 1989-03-24 ASIN: 082478023X EAN: 9780824780234 |
|
|
publisher: Raven Pr, published: 1985-06 ASIN: 0881670952 EAN: 9780881670950 |